Mendes, R. E., Castanheira, M., Gasink, L., Stone, G. G., Nichols, W. W., Flamm, R. K., & Jones, R. N. (2016). β-Lactamase Characterization of Gram-Negative Pathogens Recovered from Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized Isolates. Antimicrob Agents Chemother.
Chicago-stil citatMendes, Rodrigo E., Mariana Castanheira, Leanne Gasink, Gregory G. Stone, Wright W. Nichols, Robert K. Flamm, och Ronald N. Jones. "β-Lactamase Characterization of Gram-Negative Pathogens Recovered From Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized Isolates." Antimicrob Agents Chemother 2016.
MLA-referensMendes, Rodrigo E., et al. "β-Lactamase Characterization of Gram-Negative Pathogens Recovered From Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized Isolates." Antimicrob Agents Chemother 2016.